Professor Dmitri Sviridov
Professor Dmitri Sviridov has been working in the field of atherosclerosis and lipoprotein research for 38 years. From 1978 to 1992, he worked in the National Cardiology Research Centre in Moscow, first as a PhD student and then as a Research Officer and a Senior Research Fellow in charge of the laboratory. During these years his research was focused on interaction of platelets with the vessel wall and cholesterol and lipoprotein metabolism in the human small intestine. In 1993, he joined the Baker Medical Research Institute and moved to Australia. From 1993, Dmitri worked as a Senior Research Officer in the Laboratory of Lipoproteins and Atherosclerosis. In 1999, he was appointed a NHMRC Senior Research Fellow and in 2002 he became head of the Laboratory of Lipoproteins and Atherosclerosis at the Baker Heart Research Institute. Dmitri is a Professor in the Department of Biochemistry and Molecular Biology, School of Biomedical Science, Monash University, School of Medicine and Pharmacology, University of Western Australia, School of Medical Sciences, University of New South Walles and Department of Immunology, Microbiology and Tropical Medeicine, George Washington University, Washington, DC, USA.
Dmitri is an author of 172 papers in peer-reviewed scientific journals and books and a co-inventor in 7 international patents. He made many presentations at International meetings, presented numerous Invited Lectures, chaired sessions and was selected for oral presentations at the major International Meetings. Since 1999, Dmitri has been a recipient of 42 grants totalling 29 million dollars (NHMRC, National Heart Foundation, NIH, NMRC, Swiss National Foundation, DART). He is a member of the International and Australian Atherosclerosis Societies, American Heart Association (a Fellow of the American Heart Association from 2002), the Australian Society for Medical Research, and the Australian Vascular Biology Society. In 2002–06 and again from 2015, Dmitri was/is a Director of the Australian Atherosclerosis Society and was involved in organising meetings of Australian Atherosclerosis and Vascular Biology Societies as well as Symposium on HDL, a Satellite to the International Symposium on Atherosclerosis.
Dmitri's research at the Baker Heart and Diabetes Institute is focused on molecular, cellular and clinical aspects of lipid and lipoprotein metabolism in relation to atherosclerosis and cardiovascular disease. Specifically, it involves studying all aspects of reverse cholesterol transport, intracellular cholesterol trafficking and structural and functional studies of high density lipoprotein. He is also involved in a number of collaborative projects in other universities in Australia (Monash University, UWA, WEHI and UNSW) as well as internationally (NHLBI/NIH, George Washington University).